Ms. Kathy Gorham Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 150 Highland Ave, Gardiner, ME 04345 Phone: 207-582-3612 |
Clifton Malcolm Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 150 Highland Ave, Gardiner, ME 04345 Phone: 207-724-3930 |
Ms. Jennifer Dearborn Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 150 Highland Ave, Gardiner, ME 04345 Phone: 207-582-6268 |
News Archive
Esperance Pharmaceuticals today announced the completion of the run-in cohort of its Phase 2, randomized, multi‐center trial of EP‑100 in combination with paclitaxel for patients with advanced ovarian cancer. EP‐100 is a targeted membrane‐disrupting peptide (tMDP) designed to seek and destroy cancer cells that overexpress luteinizing hormone releasing hormone (LHRH) receptors on their surfaces.
Learning more about how to save researchers money through decision analysis is an important area of study for Steven McCabe, MD, assistant professor, University of Louisville School of Public Health and Information Sciences. He will have the chance to exchange knowledge about decision analysis with colleagues in Italy as a Fulbright Scholar.
Johns Hopkins researchers say they have identified a set of genes that appear to predict which tumors can evade detection by the body's immune system, a step that may enable them to eventually target only the patients most likely to respond best to a new class of treatment.
Many women are turning to egg freezing to promote fertility, but what happens when it isn't an option because of special medical or other conditions? And, what option is there for women who want to preserve hormonal function, not just fertility?
Scientists in the United States have come up with a breath test which can detect lung cancer in patients even when it is in the early stages of the disease.
› Verified 7 days ago